PA
ALT icon

Profund Advisors’s Altimmune ALT Stock Holding History

Profund Advisors’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$345K Buy
113,598
+10,457
+10% +$31.2K 0.01% 721
2026
Q1 		$318K Buy
103,141
+30,843
+43% +$131K 0.01% 716
2025
Q4 		$261K Buy
72,298
+38,586
+114% +$168K 0.01% 980
2025
Q3 		$127K Buy
33,712
+11,999
+55% +$46.3K ﹤0.01% 1020
2025
Q2 		$84K Sell
21,713
-8,046
-27% -$43.5K ﹤0.01% 974
2025
Q1 		$149K Sell
29,759
-791
-3% -$5.01K 0.01% 932
2024
Q4 		$220K Sell
30,550
-404
-1% -$3.09K 0.01% 959
2024
Q3 		$190K Sell
30,954
-9,807
-24% -$66.4K 0.01% 1062
2024
Q2 		$271K Sell
40,761
-94,081
-70% -$694K 0.01% 778
2024
Q1 		$1.37M Buy
+134,842
New +$1.37M 0.05% 270
2023
Q2 		– Sell
-93,919
Closed -$396K – 1073
2023
Q1 		$396K Buy
+93,919
New +$1.12M 0.02% 589

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Profund Advisors's ALT Position: Q2 2026 in Review

Profund Advisors increased its Altimmune (ALT) stake by 10% in Q2 2026, buying an estimated $31.2K and bringing the position to 113,598 shares worth $345K. The position accounts for 0.01% of the portfolio, ranked #721.

Profund Advisors first reported a position in ALT in Q1 2023 and has held it in 11 quarters since. The position peaked at $1.37M in Q1 2024. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Profund Advisors held 113,598 shares of Altimmune worth $345K as of Q2 2026.
  • Profund Advisors bought 10,457 Altimmune shares in Q2 2026, an estimated $31.2K.
  • Altimmune made up 0.01% of Profund Advisors's portfolio in Q2 2026, its #721 holding.
  • Profund Advisors first reported a position in Altimmune in Q1 2023 and has held it in 11 quarters since.
  • Profund Advisors's Altimmune position peaked at $1.37M in Q1 2024.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.